SOLIQS provides Solid Solutions for Insoluble Substances®
SOLIQS, the global drug delivery business of Abbott GmbH & Co. KG applies its formulation expertise to its customer’s compounds, focusing on increasing the bioavailability of poorly water soluble compounds, as well developing specifically designed release profiles. From the start of a cooperation, SOLIQS dedicates resources to its partners’ projects, including nominated personnel from project management, formulation and analytics. This team will accompany the project during the definition of the work program, the finalization of the development agreement, through to the execution of the program. During the program we make sure that we communicate the progress of the activities on a frequent basis. We know that each project has to be handled based on its specific characteristics and it is our aim to merge the partner's knowledge of the compound with SOLIQS’s technology expertise to achieve the target profile, meet quality expectations and stay within agreed time and budgets plans.
SOLIQS has had over 10 years of experience in partnership success with this approach. We are currently collaborating with many of the leading pharmaceutical companies in carrying out development programs and commercial manufacture with their drug substances, and we are always interested in talking to potential new partners.
Call us on ++49-621-589-2277 to talk to one of our experts . Alternatively, you can email us at welcome@soliqs.com.
|